Literature DB >> 26751099

Recombinant immune complexes as versatile and potent vaccines.

Hugh S Mason1.   

Abstract

Immune complexes (IC) used as vaccines have the potential to enhance both antibody and cell-mediated immune responses over those obtained with antigen alone. However, difficulty of manufacture represents a significant hurdle to the widespread use of IC as vaccines. Recombinant IC (RIC) and their expression in plants enable manufacturing by the coordinate expression of immunoglobulin and antigen as a fusion protein. The use of a modular RIC system facilitates insertion of antigen genes and provides a broadly applicable platform that can be adapted for a wide variety of antigens.

Keywords:  antibody fusion; immune complex; recombinant plant; transient expression; vaccine

Mesh:

Substances:

Year:  2016        PMID: 26751099      PMCID: PMC4962941          DOI: 10.1080/21645515.2015.1116655

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  15 in total

1.  Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells.

Authors:  Nadine van Montfoort; Peter A C 't Hoen; Sara M Mangsbo; Marcel G M Camps; Peter Boross; Cornelis J M Melief; Ferry Ossendorp; J Sjef Verbeek
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

2.  Novel vaccination approach for dengue infection based on recombinant immune complex universal platform.

Authors:  Mi-Young Kim; Rajko Reljic; Jacquelyn Kilbourne; Ivonne Ceballos-Olvera; Moon-Sik Yang; Jorge Reyes-del Valle; Hugh S Mason
Journal:  Vaccine       Date:  2015-02-26       Impact factor: 3.641

3.  Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells.

Authors:  Andrés A Herrada; Francisco J Contreras; Jaime A Tobar; Rodrigo Pacheco; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-06       Impact factor: 11.205

4.  Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.

Authors:  Waranyoo Phoolcharoen; Seong H Bhoo; Huafang Lai; Julian Ma; Charles J Arntzen; Qiang Chen; Hugh S Mason
Journal:  Plant Biotechnol J       Date:  2011-02-01       Impact factor: 9.803

5.  The generation of memory cells. II. Generation of B memory cells with preformed antigen-antibody complexes.

Authors:  G G Klaus
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

6.  Enhanced immunologic sensitization of mice by the simultaneous injection of antigen and specific antiserum. II. Effect of varying the antigen-antibody ratio and the amount of immune complex injected.

Authors:  S L Morrison; G Terres
Journal:  J Immunol       Date:  1966-05       Impact factor: 5.422

7.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.

Authors:  Richard Strasser; Johannes Stadlmann; Matthias Schähs; Gabriela Stiegler; Heribert Quendler; Lukas Mach; Josef Glössl; Koen Weterings; Martin Pabst; Herta Steinkellner
Journal:  Plant Biotechnol J       Date:  2008-03-13       Impact factor: 9.803

8.  The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120.

Authors:  Catarina E Hioe; Maria Luisa Visciano; Rajnish Kumar; Jianping Liu; Ethan A Mack; Rachel E Simon; David N Levy; Michael Tuen
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

9.  Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG.

Authors:  Ilaria Pepponi; Gil R Diogo; Elena Stylianou; Craig J van Dolleweerd; Pascal M W Drake; Matthew J Paul; Laura Sibley; Julian K-C Ma; Rajko Reljic
Journal:  Plant Biotechnol J       Date:  2014-03-13       Impact factor: 9.803

10.  Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.

Authors:  A Regnault; D Lankar; V Lacabanne; A Rodriguez; C Théry; M Rescigno; T Saito; S Verbeek; C Bonnerot; P Ricciardi-Castagnoli; S Amigorena
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more
  4 in total

1.  Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.

Authors:  Andrew G Diamos; Dalia Larios; Lauren Brown; Jacquelyn Kilbourne; Hyun Soon Kim; Divyasha Saxena; Kenneth E Palmer; Hugh S Mason
Journal:  Vaccine       Date:  2018-11-17       Impact factor: 3.641

2.  High Level Production of Monoclonal Antibodies Using an Optimized Plant Expression System.

Authors:  Andrew G Diamos; Joseph G L Hunter; Mary D Pardhe; Sun H Rosenthal; Haiyan Sun; Bonnie C Foster; Michelle P DiPalma; Qiang Chen; Hugh S Mason
Journal:  Front Bioeng Biotechnol       Date:  2020-01-17

3.  A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant.

Authors:  Andrew G Diamos; Mary D Pardhe; Haiyan Sun; Joseph G L Hunter; Jacquelyn Kilbourne; Qiang Chen; Hugh S Mason
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

4.  Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity.

Authors:  Andrew G Diamos; Mary D Pardhe; Haiyan Sun; Joseph G L Hunter; Tsafrir Mor; Lydia Meador; Jacquelyn Kilbourne; Qiang Chen; Hugh S Mason
Journal:  Vaccine       Date:  2020-03-12       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.